namzaric
Generic: memantine hydrochloride and donepezil hydrochloride
namzaric: sourced relationships with 2 companies · 1 FDA decision.
namzaric evidence translation
What we can confirm
1 FDA record
What it means
More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
What is verified about namzaric, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
moderate to severe dementia of an Alzheimer's type
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| AbbVie Inc. (ABBV) Reported 2014-12-23 · Current development: unknownSource | Approved |
| Adamas Pharmaceuticals Inc (ADMS) moderate to severe dementia of an Alzheimer's type | Approved |
FDA Decisions1 records
Frequently asked questions
Which companies have sourced relationships with namzaric?
namzaric has dated SEC/FDA relationship records for AbbVie Inc., Adamas Pharmaceuticals Inc.
What is namzaric's latest FDA decision?
The most recent tracked FDA decision for namzaric is Approval, dated December 23, 2014.